bioAffinity Technologies annual operating expenses
2021
2022
2023
2024
2025
bioAffinity Technologies Operating Expenses Growth & History (BIAF)
bioAffinity Technologies's operating expenses was $16.7M for fiscal 2025.
View full bioAffinity Technologies company overviewbioAffinity Technologies annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $16.7M | −$1.6M | −8.63% |
| 2024 | 2024-12-31 | $18.3M | $7.8M | +74.34% |
| 2023 | 2023-12-31 | $10.5M | $6.5M | +161.61% |
| 2022 | 2022-12-31 | $4.0M | $1.8M | +81.97% |
| 2021 | 2021-12-31 | $2.2M | — | — |
bioAffinity Technologies quarterly operating expenses
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.8M | $1.1M | +28.02% |
| Q1 2026 | 2026-03-31 | $5.0M | $487,767 | +10.89% |
| Q4 2025 | 2025-12-31 | $4.7M | −$424,370 | −8.23% |
| Q3 2025 | 2025-09-30 | $3.7M | −$585,338 | −13.54% |
| Q2 2025 | 2025-06-30 | $3.8M | −$700,407 | −15.62% |
| Q1 2025 | 2025-03-31 | $4.5M | $129,115 | +2.97% |
| Q4 2024 | 2024-12-31 | $5.2M | $598,386 | +13.13% |
| Q3 2024 | 2024-09-30 | $4.3M | $1.7M | +66.77% |
| Q2 2024 | 2024-06-30 | $4.5M | $2.7M | +149.46% |
| Q1 2024 | 2024-03-31 | $4.4M | $2.8M | +179.15% |
| Q4 2023 | 2023-12-31 | $4.6M | $2.9M | +180.12% |
| Q3 2023 | 2023-09-30 | $2.6M | $1.6M | +165.36% |
| Q2 2023 | 2023-06-30 | $1.8M | $1.1M | +162.39% |
| Q1 2023 | 2023-03-31 | $1.6M | $831,848 | +114.42% |
| Q4 2022 | 2022-12-31 | $1.6M | — | — |
| Q3 2022 | 2022-09-30 | $977,160 | $450,867 | +85.67% |
| Q2 2022 | 2022-06-30 | $685,279 | — | — |
| Q1 2022 | 2022-03-31 | $727,043 | — | — |
| Q3 2021 | 2021-09-30 | $526,293 | — | — |
bioAffinity Technologies operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, bioAffinity Technologies's operating expenses increased from $2.2M to $16.7M, a change of $14.5M. The latest reported quarter, Q2 2026, shows $4.8M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review bioAffinity Technologies source filings ↗